Cargando…
Plasma lncRNA FEZF1-AS1 as a potential biomarker for diagnosis of non-small-cell lung carcinoma
Diagnosis of numerous cancers has been closely linked to the expression of certain long non-coding RNAs. This study aimed to evaluate levels of plasma FEZ family zinc finger 1 antisense RNA 1 (FEZF1-AS1) relative to non-small-cell lung carcinoma (NSCLC) diagnosis. The level of FEZF1-AS1 in the blood...
Autores principales: | Huang, Yajie, Liu, Guangjie, Ma, Handie, Tian, Yanpeng, Huang, Changjie, Liu, Fang, Jia, Yuxuan, Jiang, Da |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329120/ https://www.ncbi.nlm.nih.gov/pubmed/32590821 http://dx.doi.org/10.1097/MD.0000000000021019 |
Ejemplares similares
-
FEZF1-AS1 functions as an oncogenic lncRNA in retinoblastoma
por: Quan, Lian-Jiao, et al.
Publicado: (2019) -
LncRNA ALMS1-IT1 is a novel prognostic biomarker and correlated with immune infiltrates in colon adenocarcinoma
por: Lin, Yuning, et al.
Publicado: (2022) -
Association of LncRNA PCBP1-AS1 with cancer occurrence and development: A review
por: Wu, Yanping, et al.
Publicado: (2023) -
LncRNA LOXL1-AS1 expression in cancer prognosis: A meta-analysis
por: Wang, Xuhua, et al.
Publicado: (2022) -
LncRNA DIRC1 is a novel prognostic biomarker and correlated with immune infiltrates in stomach adenocarcinoma
por: Lin, Yuning, et al.
Publicado: (2022)